An Observational Study to Evaluate the Treatment of Newvast ® Tab(Atorvastatin) in Korean Patients With Dyslipidemia
Condition:   Dyslipidemia Intervention:   Drug: single arm, single group(No interventional) Sponsor:   Hanmi Pharmaceutical Company Limited Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2022 Category: Research Source Type: clinical trials